title: Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.
abstract: "Browning," the appearance and activation of brown-in-white (brite) adipose cells within inguinal white adipose tissue (iWAT), and induction of uncoupling protein 1 (UCP1) correlate with fibroblast growth factor-21 (FGF21)-induced weight loss and glucose homeostasis improvements. Therefore, antiobesity therapies targeting browning and brite adipocyte activation are currently being sought. To test the dependence of weight loss on browning, we examined whether this event was responsible for FGF21-Fc's beneficial effects. Lean and diet-induced obese mice housed at 21°C or 30°C that received FGF21-Fc exhibited similar degrees of body weight reduction and glucose homeostasis improvement. Substantial browning of iWAT occurred only in FGF21-Fc-treated lean mice housed at 21°C. Further, FGF21-Fc-treated Ucp1(-/-) mice showed robust improvements in body weight, glucose homeostasis, and plasma lipids, associated with increased energy expenditure and FGF21-Fc-induced Ppargc1 expression in iWAT. We conclude that FGF21 requires neither UCP1 nor brite adipocytes to elicit weight loss and improve glucose homeostasis.
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Murielle M
authors.initials: MM
authors.lastname: Véniant
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Glenn
authors.initials: G
authors.lastname: Sivits
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Joan
authors.initials: J
authors.lastname: Helmering
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Renee
authors.initials: R
authors.lastname: Komorowski
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Jae
authors.initials: J
authors.lastname: Lee
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Wei
authors.initials: W
authors.lastname: Fan
authors.affiliation: Department of Pathology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Moyer
authors.affiliation: Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: dlloyd@amgen.com.
authors.forename: David J
authors.initials: DJ
authors.lastname: Lloyd
mesh_terms: D052437:Adipocytes, Brown / Q000187:drug effects / Q000473:pathology; D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000503:physiopathology; D052436:Adipose Tissue, White / Q000187:drug effects* / Q000503:physiopathology; D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D004032:Diet / Q000009:adverse effects; D004734:Energy Metabolism / Q000187:drug effects; D005346:Fibroblast Growth Factors / Q000627:therapeutic use*; D005786:Gene Expression Regulation / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007473:Ion Channels / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D024101:Mitochondrial Proteins / Q000235:genetics; D009765:Obesity / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics / Q000503:physiopathology; D022722:Thermogenesis / Q000187:drug effects; D000071256:Uncoupling Protein 1
chemical_list: D019440:Anti-Obesity Agents; D007004:Hypoglycemic Agents; D007473:Ion Channels; D024101:Mitochondrial Proteins; C000604372:Ucp1 protein, mouse; D000071256:Uncoupling Protein 1; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors; D005947:Glucose